Hook & Thesis
Lockheed Martin (LMT) went from relative strength into a sharp correction after a Q1 2026 earnings miss and an outsized selloff in March. The selloff has pushed the stock well below key moving averages and into oversold technical territory, creating a tradeable setup for investors willing to take a medium-to-long duration view. My thesis: the headline miss is largely short-term noise against a durable defense spending backdrop; a disciplined long at current levels offers asymmetric upside toward prior analyst targets if guidance holds and contract flows continue.
Two facts drive the thesis. First, the company reaffirmed full-year guidance even after Q1 weakness (management statement summarized in coverage on 05/04/2026). Second, the macro picture for defense is constructive: the U.S. approved over $8.6 billion in arms sales to Gulf partners and Israel approved a major procurement that explicitly includes F-35s (news on 05/03/2026). Those are not academic items - they represent concrete near-term revenue and replenishment demand that should support funding and order flow over the next several quarters.
What Lockheed Does and Why Markets Care
Lockheed Martin is a global security and aerospace company with four business segments: Aeronautics (combat and mobility aircraft, F-35 family upgrades), Missiles & Fire Control (air and missile defense systems, tactical missiles), Rotary & Mission Systems (helicopters, radars, sensors, C2, cyber), and Space (satellites, launch, strategic systems). Investors care because the business is a high-visibility prime contractor to governments with multi-year programs, recurring sustainment revenue, and high margin programs (F-35 sustainment, missile replenishment). In environments of geopolitical tension, these characteristics translate into steady cash flow and upside if program deliveries and follow-on orders accelerate.
What the numbers say
The market is already repricing that profile aggressively: LMT trades at $512.61 with a market cap of roughly $118.2 billion and an enterprise value of about $137.0 billion. Trailing earnings per share sits around $20.79 and the stock is trading near a P/E in the mid-20s (roughly 24.7 - 25.1 per reported ratios). Valuation is not cheap on an absolute basis (price-to-book near 15.8), but on an EV/sales of 1.82 and EV/EBITDA around 15.8 the company still commands a premium attributable to its program backlog and stable cash generation. Free cash flow in the reported period was about $5.66 billion - not trivial for a $118 billion company - yet Q1 produced a headline decline in earnings and negative free cash flow that spurred the selloff.
Technically, the stock is deeply oversold: RSI 25.1 and price sitting well below the 50-day ($609) and 20-day ($562.85) averages. Short interest and short-volume data show the name has been actively traded from the short side in recent weeks, which can amplify moves both down and, on a reversal, up. That dynamic suggests a trade with a well-defined risk (stop) and realistic time to mean reversion.
Valuation framing
At $512.61 the market is pricing Lockheed for continued program delivery but with a premium baked in for program quality and margins. PE in the mid-20s and EV/EBITDA ~15.8 imply the market expects solid free cash conversion going forward. Compare that to the company’s 52-week range: a high of $692 (03/02/2026) and a low of $410.11 (07/22/2025). The stock is closer to the lower half of that range today, while several analyst price targets remain north of $650 per coverage on 05/04/2026. If management executes and defense demand translates into orders and sustained FCF, reversion toward $600+ is plausible; if not, the downside could revisit the prior low near $410.
Catalysts (what could re-rate the stock)
- Confirmed contract awards and order announcements tied to F-35 sustainment or missile/system replenishment following the recent arms sales approvals (news dated 05/03/2026).
- Better-than-expected Q2 operational metrics: margin recovery, positive free cash flow swing, or clearer cadence on deliveries.
- Macro tailwinds: renewed replenishment buys by allies after regional incidents (e.g., the Iran-UAE tensions reported on 05/04/2026) that force higher inventory purchases.
- Analyst revisions higher on earnings and FCF reconvergence to previous levels, which can compress the P/E back toward historical peers.
Trade plan (actionable)
| Leg | Detail |
|---|---|
| Direction | Long |
| Entry | $512.61 |
| Stop loss | $470.00 |
| Target | $650.00 |
| Horizon | Long term (180 trading days) - allow time for program news, order flow, and re-rating back toward analyst/intrinsic targets. |
| Risk level | Medium |
Rationale for levels: entry is current market price, stop at $470 is below the nearest technical consolidation and preserves capital if orders or guidance deterioration emerges. The $650 target sits between recent analyst targets cited in coverage and the prior $692 peak - a realistic swing target if the company re-establishes normal FCF and the defense tailwind continues.
Position sizing & risk management
This setup is not a low-volatility income trade. Use position sizing so that a stop hit at $470 results in a loss you can tolerate (for many retail-sized accounts this implies single-digit percentage allocation). Re-evaluate the position on any meaningful news (contract wins, updated guidance) and tighten stops if the stock regains the 20-day EMA and shows higher-volume acceptance above it.
Risks & Counterarguments
- Execution risk: The Q1 miss highlighted the possibility of program execution problems or timing slippage that could extend through subsequent quarters. If deliveries continue to miss, the valuation premium will compress further.
- Cash-flow pressure: Although free cash flow was $5.66 billion in the reported period, the company posted negative free cash flow in Q1. If that trend persists, balance sheet pressure and lower buybacks/dividend support could weigh on the stock.
- Geopolitical/appropriations risk: Defense budgets and procurement cycles are subject to politics. A delay in appropriations or a strategic pivot by major customers could reduce near-term orders despite favorable headlines.
- Macroeconomic and rates environment: Rising rates or risk-off flows can further punish high-PE cyclicals; LMT’s P/B and P/E imply sensitivity to multiple contraction if macro deteriorates.
- Technical risk: The stock is in a correction; momentum could remain negative and revisit previous lows around $410 if selling pressure resumes.
Counterargument: The selloff is signaling a structural change - higher program risk, weaker margins, or customer funding problems - and the market is rightly re-rating the business. In that scenario, buying the dip is premature and losses could be material. That perspective argues for waiting for signs of margin stabilization and positive FCF before re-entering.
What would change my mind
I will step away from the long if: (1) management withdraws or materially revises full-year guidance downward; (2) subsequent quarters show persistent negative free cash flow without a credible path back to positive FCF; or (3) material program cancellations or a meaningful loss of expected orders (e.g., a major customer deferral). Conversely, evidence of contract awards tied to recent arms approvals, visible improvement in cash conversion, and analyst upgrades would validate the thesis and warrant adding to the position on strength.
Conclusion
This is a tactical, event-driven long: buy the overshoot caused by a Q1 earnings miss, but do so with a concrete stop and a realistic timeline. The defense backdrop is constructive - U.S. arms approvals and allied procurements create a plausible path back to prior highs - but execution risk and cash conversion remain real threats. If you believe guidance holds and the company can return to normal free cash flow over the next few quarters, the risk/reward at $512.61 is attractive toward a $650 target. If you are skeptical about program execution, wait for clearer signs of margin and cash-flow recovery before committing capital.
Trade summary: Long LMT at $512.61, stop $470.00, target $650.00, horizon long term (180 trading days). Size the position so a stop-hit loss is consistent with your risk tolerance.